GlaxoSmithKline PLC (OTC Pink - Current Information:GLAXF)

19.96
Delayed Data
As of Jun 18
 -0.84 / -4.04%
Today’s Change
16.50
Today|||52-Week Range
21.26
+12.20%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Major
MARKET CAP
$100.4B

Company Description

GlaxoSmithKline Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the following segments: Pharmaceuticals; Pharmaceuticals R&D; Vaccines and Consumer Healthcare. The Pharmaceuticals segment focuses on developing medicines in respiratory and infectious diseases, oncology, and immuno-inflammation. The Pharmaceuticals R&D segment focuses on science related to the immune system, the use of human genetics and advanced technologies, and is driven by the multiplier effect of Science x Technology x Culture. The Vaccines segment produces pediatric and adult vaccines to prevent a range of infectious diseases including, hepatitis A and B, diphtheria, tetanus and whooping cough, measles, mumps and rubella, polio, typhoid, influenza, and bacterial meningitis. The Consumer Healthcare segment develops and markets brands in the oral health, pain relief, respiratory, nutrition and gastro intestinal, and skin health categories. The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom.

Contact Information

GlaxoSmithKline Plc
980 Great West Road
Middlesex Greater London TW8 9GS
P:442080475000
Investor Relations:

Employees

Shareholders

Mutual fund holders--
Individual stakeholders--
Other institutional--

Top Executives

Emma N. WalmsleyChief Executive Officer & Executive Director
Iain James MackayChief Financial Officer & Executive Director
Jon EllisVP & Head-Technology Business Development
Karenann K. TerrellChief Digital & Technology Officer
Hal V. BarronExecutive Director & Chief Scientific Officer